Salt intake, endothelial cell signaling, and progression of kidney disease

被引:77
作者
Sanders, PW
机构
[1] Univ Alabama, Dept Med, Div Nephrol, Ctr Nephrol Res & Training, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Div Nephrol, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Med, Div Nephrol, Cell Adhes & Matrix Res Ctr, Birmingham, AL 35294 USA
[4] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA
[5] Dept Vet Affairs Med Ctr, Birmingham, AL USA
关键词
endothelium; vascular disease; nitric oxide; gene expression; hypertension;
D O I
10.1161/01.HYP.0000114022.20424.22
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
It has been known for decades that increased dietary intake of salt ( NaCl) shortens the life span of rats in a dose-dependent fashion. This review focuses specifically on the recently described biological effect and consequences of increased salt ingestion on the endothelium through a mechanism that is independent of blood pressure. Changes in salt intake are recognized by endothelial cells in the vascular tree and glomeruli through a physical process that promotes a series of signaling events involved in transcriptional regulation of genes that include transforming growth factor-beta1 (TGF-beta1) and the endothelial isoform of nitric oxide synthase (NOS3). A balance is struck between TGF-beta1 and NOS3 as salt intake varies and creates a negative feedback loop, because TGF-beta1 increased expression of NOS3 and NO inhibited production of TGF-beta1 in healthy rats. Changes in this feedback system have been observed in salt-sensitive hypertension and appear to impact end-organ damage, particularly the kidney. The data support an important benefit to reduction of salt intake in the setting of chronic kidney disease.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 74 条
[1]   Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis [J].
Akagi, Y ;
Isaka, Y ;
Arai, M ;
Kaneko, T ;
Takenaka, M ;
Moriyama, T ;
Kaneda, Y ;
Ando, A ;
Orita, Y ;
Kamada, T ;
Ueda, N ;
Imai, E .
KIDNEY INTERNATIONAL, 1996, 50 (01) :148-155
[2]   Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells [J].
Anderson, PW ;
Zhang, XY ;
Tian, J ;
Correale, JD ;
Xi, PX ;
Yang, D ;
Graf, K ;
Law, RE ;
Hsueh, WA .
KIDNEY INTERNATIONAL, 1996, 50 (03) :745-753
[3]   Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans [J].
Bech, JN ;
Nielsen, CB ;
Ivarsen, P ;
Jensen, KT ;
Pedersen, EB .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (05) :F914-F923
[4]   SUPERIORITY OF SALT RESTRICTION OVER DIURETICS IN REDUCING RENAL HYPERTROPHY AND INJURY IN UNINEPHRECTOMIZED SHR [J].
BENSTEIN, JA ;
FEINER, HD ;
PARKER, M ;
DWORKIN, LD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (06) :F1675-F1681
[5]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[6]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[7]   SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[8]   NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE [J].
BORDER, WA ;
NOBLE, NA ;
YAMAMOTO, T ;
HARPER, JR ;
YAMAGUCHI, Y ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
NATURE, 1992, 360 (6402) :361-364
[9]   CYTOKINES IN KIDNEY-DISEASE - THE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BORDER, WA ;
NOBLE, NA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) :105-113
[10]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610